Intravenous Immunoglobulin G and Anti-D as Therapeutic Interventions in Immune Thrombocytopenic Purpura

By Blanchette FRCP V.   Carcao MD F.  

Transfusion and Apheresis Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 279-288

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac^®) in chronic immune thrombocytopenic purpura

By Aledort L. M.   Salama A.   Kovaleva L.   Robak T.   Newland A. C.   Nugent D. J.   Brenner B.   Zenker O.  

Hematology, Vol. 12, Iss. 4, 2007-08 ,pp. : 289-295

Maney Publishing

Access to resources Recommend Favorite

Intravenous immunoglobulin and Anti-D in Idiopathic Thrombocytopenic Purpura (ITP): Mechanisms of Action

By Lazarus A.H.   Freedman J.   Semple J.W.  

Transfusion and Apheresis Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Intravenous immunoglobulin and Anti-D in Idiopathic Thrombocytopenic Purpura (ITP): Mechanisms of Action

By Lazarus A.H.   Freedman J.   Semple J.W.  

Transfusion Science, Vol. 19, Iss. 3, 1998-09 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of Privigen^®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura

By Robak T.   Salama A.   Kovaleva L.   Vyhovska Y.   Davies S. V.   Mazzucconi M. G.   Zenker O.   Kiessling P.    

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 227-236

Maney Publishing

Access to resources Recommend Favorite